JIANGSU AOYANG HEALTH INDUSTRY CO.LTD. Financials Jiangsu Aoyang Health Industry Co.ltd.
Equities
002172
CNE1000006Y7
Textiles & Leather Goods
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 CNY | +1.40% |
|
+3.94% | -23.48% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,982 | 2,864 | 2,290 | 3,086 | 3,162 | 2,902 |
| Enterprise Value (EV) 1 | 4,790 | 5,104 | 3,568 | 4,230 | 3,644 | 3,414 |
| P/E ratio | 384 x | -6.8 x | -5.07 x | -3.01 x | -207 x | 63.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.63 x | 0.96 x | 0.74 x | 2.16 x | 1.56 x | 1.34 x |
| EV / Revenue | 1.02 x | 1.71 x | 1.16 x | 2.96 x | 1.8 x | 1.57 x |
| EV / EBITDA | 25.2 x | -26.3 x | -41 x | 21.4 x | 20.2 x | 21.6 x |
| EV / FCF | -3.05 x | -25.5 x | 4.45 x | -2.81 x | 8.4 x | 105 x |
| FCF Yield | -32.8% | -3.91% | 22.5% | -35.6% | 11.9% | 0.95% |
| Price to Book | 1.59 x | 2.03 x | 2.4 x | 48.9 x | 71.4 x | 41 x |
| Nbr of stocks (in thousands) | 776,481 | 765,732 | 765,732 | 765,732 | 765,732 | 765,732 |
| Reference price 2 | 3.840 | 3.740 | 2.990 | 4.030 | 4.130 | 3.790 |
| Announcement Date | 4/11/19 | 4/15/20 | 3/30/21 | 4/28/22 | 3/23/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4,711 | 2,982 | 3,083 | 1,429 | 2,021 | 2,174 |
| EBITDA 1 | 189.7 | -194.1 | -86.95 | 197.5 | 180.8 | 157.8 |
| EBIT 1 | -49.32 | -423.5 | -390.7 | -13.82 | 115.2 | 93.53 |
| Operating Margin | -1.05% | -14.2% | -12.67% | -0.97% | 5.7% | 4.3% |
| Earnings before Tax (EBT) 1 | -6.623 | -555.1 | -438.3 | -839.5 | -0.9642 | 69.94 |
| Net income 1 | 10.36 | -425.2 | -459 | -1,039 | -15.39 | 49.68 |
| Net margin | 0.22% | -14.26% | -14.89% | -72.68% | -0.76% | 2.29% |
| EPS 2 | 0.0100 | -0.5500 | -0.5900 | -1.340 | -0.0200 | 0.0600 |
| Free Cash Flow 1 | -1,573 | -199.8 | 802.1 | -1,506 | 434 | 32.44 |
| FCF margin | -33.39% | -6.7% | 26.01% | -105.36% | 21.47% | 1.49% |
| FCF Conversion (EBITDA) | - | - | - | - | 240.1% | 20.56% |
| FCF Conversion (Net income) | - | - | - | - | - | 65.29% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/11/19 | 4/15/20 | 3/30/21 | 4/28/22 | 3/23/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,808 | 2,240 | 1,279 | 1,144 | 481 | 512 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 9.53 x | -11.54 x | -14.71 x | 5.79 x | 2.662 x | 3.244 x |
| Free Cash Flow 1 | -1,573 | -200 | 802 | -1,506 | 434 | 32.4 |
| ROE (net income / shareholders' equity) | -2.49% | -32.9% | -39.1% | -162% | -40.5% | 98.8% |
| ROA (Net income/ Total Assets) | -0.51% | -4.11% | -3.82% | -0.17% | 2.2% | 2.36% |
| Assets 1 | -2,022 | 10,335 | 12,006 | 616,566 | -698.2 | 2,103 |
| Book Value Per Share 2 | 2.420 | 1.840 | 1.240 | 0.0800 | 0.0600 | 0.0900 |
| Cash Flow per Share 2 | 1.160 | 0.8000 | 1.920 | 1.280 | 1.290 | 0.7000 |
| Capex 1 | 1,113 | 253 | 177 | 221 | 193 | 63.6 |
| Capex / Sales | 23.62% | 8.49% | 5.75% | 15.47% | 9.56% | 2.93% |
| Announcement Date | 4/11/19 | 4/15/20 | 3/30/21 | 4/28/22 | 3/23/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -23.48% | 306M | |
| -2.61% | 2.87B | |
| -1.79% | 1.19B | |
| -10.86% | 883M | |
| +8.68% | 836M | |
| +25.39% | 795M | |
| -3.19% | 776M | |
| +31.35% | 603M | |
| +11.29% | 481M | |
| -19.49% | 419M |
- Stock Market
- Equities
- 002172 Stock
- Financials Jiangsu Aoyang Health Industry Co.ltd.
